Waypoint Capital Acquires 70% Stake in Allergy Partners

December 20, 2021

Waypoint Capital (through an affiliate) acquired a 70% majority stake in Allergy Partners, the largest U.S. group of single-specialty allergy and asthma practices. Allergy Partners — led by CEO David Brown and operating dozens of practice hubs across multiple states — will continue to be led by its current management as Waypoint provides growth capital to expand access and accelerate strategic initiatives; terms were not disclosed.

Buyers
Waypoint Capital
Targets
Allergy Partners
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.